THE government will examine Sun Pharma

Novartis yesterday underlined its determination to expand beyond its core drugs business, but denied that spending $50bn on Alcon put it in the same category as other pharmaceuticals groups diversifying to counter falling drug discovery rates or looming patent expiries.

A

When one of the top 20 pharma giants in the world, Eisai Pharmaceuticals of Japan, inaugurated its global research and development and production facility in Visakhapatnam last month, it was not just another feather in the cap of the city that is being dubbed as the

Demand for quality healthcare fuelled by economic prosperity is opening up a new market beyond the metros to India

The fi rst report of the Mashelkar Committee on patent issues was accused of plagiarism and the committee was asked by the government to rexamine its recommendations. The second report of this committee poses a different set of problems.

Dabur, Godrej Sara Lee plans in place to grow naturals variants.

The mosquito repellent cream category has become active this season with both Dabur and Godrej Sara Lee planning to grow the category based on the

Very high levels of a range of pharmaceuticals have been reported recently in the effluent from a wastewater treatment plant near Hyderabad, India. The plant serves approximately 90 manufacturers of bulk drugs that primarily are exported to the world market. Fluoroquinolone antibiotics were found at levels that are highly toxic to various microorganisms.

Patancheru, near Hyderabad, India, is a major production site for the global bulk drug market. Approximately 90 manufacturers send their wastewater to a common treatment plant in Patancheru. Extraordinary high levels of a wide range of pharmaceuticals have recently been demonstrated in the treated effluent. As little as 0.2% of this effluent can strongly reduce the growth rate of tadpoles, but the underlying mechanisms of toxicity are not known. To begin addressing how the effluent affects aquatic vertebrates, rainbow trout (Oncorhynchus mykiss) were exposed to 0.2% effluent for 5 d.

Two pharmaceutical companies have sought permission from the Indian Council of Medical Research to start clinical trials for swine flu vaccine prepared by them using a new method.

Pages